152 related articles for article (PubMed ID: 8440681)
41. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7.
Leslie CC; Voelker DR; Channon JY; Wall MM; Zelarney PT
Biochim Biophys Acta; 1988 Dec; 963(3):476-92. PubMed ID: 3143418
[TBL] [Abstract][Full Text] [Related]
42. Determination of platelet-activating factor acetylhydrolase activity by blotting, beta-radioluminescence, and ultrahigh-sensitivity television camera detection.
Akiyama M; Sugatani J; Suzuki Y; Miwa M
Anal Biochem; 1994 May; 218(2):295-9. PubMed ID: 8074283
[TBL] [Abstract][Full Text] [Related]
43. Purification of a new, calcium-independent, high molecular weight phospholipase A2/lysophospholipase (phospholipase B) from guinea pig intestinal brush-border membrane.
Gassama-Diagne A; Fauvel J; Chap H
J Biol Chem; 1989 Jun; 264(16):9470-5. PubMed ID: 2722844
[TBL] [Abstract][Full Text] [Related]
44. The catalytic subunit of bovine brain platelet-activating factor acetylhydrolase is a novel type of serine esterase.
Hattori M; Adachi H; Tsujimoto M; Arai H; Inoue K
J Biol Chem; 1994 Sep; 269(37):23150-5. PubMed ID: 8083218
[TBL] [Abstract][Full Text] [Related]
45. The structure and function of platelet-activating factor acetylhydrolases.
Derewenda ZS; Derewenda U
Cell Mol Life Sci; 1998 May; 54(5):446-55. PubMed ID: 9645224
[TBL] [Abstract][Full Text] [Related]
46. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.
Liu J; Chen R; Marathe GK; Febbraio M; Zou W; McIntyre TM
Circ Res; 2011 Feb; 108(4):469-77. PubMed ID: 21183738
[TBL] [Abstract][Full Text] [Related]
47. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.
Tjoelker LW; Wilder C; Eberhardt C; Stafforini DM; Dietsch G; Schimpf B; Hooper S; Le Trong H; Cousens LS; Zimmerman GA; Yamada Y; McIntyre TM; Prescott SM; Gray PW
Nature; 1995 Apr; 374(6522):549-53. PubMed ID: 7700381
[TBL] [Abstract][Full Text] [Related]
48. Platelet-activating factor acetylhydrolase activity in red blood cell-stroma from patients with cerebral thrombosis.
Yoshida H; Satoh K; Imaizumi T; Takamatsu S; Hiramoto M; Shoji B; Takamatsu M
Acta Neurol Scand; 1992 Aug; 86(2):199-203. PubMed ID: 1414232
[TBL] [Abstract][Full Text] [Related]
49. Release of platelet-activating factor in systemic lupus erythematosus.
Tetta C; Bussolino F; Modena V; Montrucchio G; Segoloni G; Pescarmona G; Camussi G
Int Arch Allergy Appl Immunol; 1990; 91(3):244-56. PubMed ID: 2354868
[TBL] [Abstract][Full Text] [Related]
50. Deficiency of plasma platelet-activating factor acetylhydrolase: roles of blood cells.
Yoshida H; Satoh K; Koyama M; Hiramoto M; Takamatsu S
Am J Hematol; 1996 Nov; 53(3):158-64. PubMed ID: 8895685
[TBL] [Abstract][Full Text] [Related]
51. Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II.
Matsuzawa A; Hattori K; Aoki J; Arai H; Inoue K
J Biol Chem; 1997 Dec; 272(51):32315-20. PubMed ID: 9405438
[TBL] [Abstract][Full Text] [Related]
52. A yeast PAF acetylhydrolase ortholog suppresses oxidative death.
Foulks JM; Weyrich AS; Zimmerman GA; McIntyre TM
Free Radic Biol Med; 2008 Aug; 45(4):434-42. PubMed ID: 18489912
[TBL] [Abstract][Full Text] [Related]
53. Identification of a major PAF acetylhydrolase in human serum/plasma as a 43 kDa glycoprotein containing about 9 kDa asparagine-conjugated sugar chain(s).
Akiyama M; Sugatani J; Suzuki T; Suzuki Y; Miwa M
J Biochem; 1998 May; 123(5):786-9. PubMed ID: 9562606
[TBL] [Abstract][Full Text] [Related]
54. Human macrophages secret platelet-activating factor acetylhydrolase.
Stafforini DM; Elstad MR; McIntyre TM; Zimmerman GA; Prescott SM
J Biol Chem; 1990 Jun; 265(17):9682-7. PubMed ID: 2351664
[TBL] [Abstract][Full Text] [Related]
55. Determination of phospholipase activity of PAF acetylhydrolase.
Stafforini DM; McIntyre TM
Free Radic Biol Med; 2013 Jun; 59():100-7. PubMed ID: 22659315
[TBL] [Abstract][Full Text] [Related]
56. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
Tselepis AD; John Chapman M
Atheroscler Suppl; 2002 Dec; 3(4):57-68. PubMed ID: 12573364
[TBL] [Abstract][Full Text] [Related]
57. Membrane-bound plasma platelet activating factor acetylhydrolase acts on substrate in the aqueous phase.
Min JH; Jain MK; Wilder C; Paul L; Apitz-Castro R; Aspleaf DC; Gelb MH
Biochemistry; 1999 Sep; 38(39):12935-42. PubMed ID: 10504265
[TBL] [Abstract][Full Text] [Related]
58. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor.
Suzuki Y; Miwa M; Harada M; Matsumoto M
Eur J Biochem; 1988 Feb; 172(1):117-20. PubMed ID: 3345757
[TBL] [Abstract][Full Text] [Related]
59. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
Stafforini DM; McIntyre TM; Carter ME; Prescott SM
J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
[TBL] [Abstract][Full Text] [Related]
60. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases.
Stafforini DM; Sheller JR; Blackwell TS; Sapirstein A; Yull FE; McIntyre TM; Bonventre JV; Prescott SM; Roberts LJ
J Biol Chem; 2006 Feb; 281(8):4616-23. PubMed ID: 16371369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
